Dysglycemia and liver lipid content determine the relationship of insulin resistance with hepatic OXPHOS capacity in obesity
S. Kahl(Düsseldorf University Hospital), Michael Roden(Düsseldorf University Hospital), Sandra Trenkamp(Düsseldorf University Hospital), Kalliopi Pafili(Düsseldorf University Hospital), Klaus Straßburger(Deutsches Diabetes-Zentrum e.V.), Giovanni Pacini(National Research Council), Nina Trinks(Deutsches Diabetes-Zentrum e.V.), Frank A. Granderath(Hochschule Düsseldorf University of Applied Sciences), Iréne Esposito(Heinrich Heine University Düsseldorf), Lucia Mastrototaro(Women‘s Healthcare Group), Bedair Dewidar(Tanta University), Theresia Sarabhai(Düsseldorf University Hospital), Matthias Schlensak(Hochschule Düsseldorf University of Applied Sciences)
Cited by 18
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
The integrative biology of type 2 diabetes
|Nature|2019|1.1k